IN8bio's total assets for Q2 2026 were $21.75M, a decrease of -17.21% from the previous quarter. INAB total liabilities were $3.38M for the fiscal quarter, a -2.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.